Literature DB >> 17084580

Techniques for the placement of hepatic artery catheters for regional chemotherapy in unresectable liver metastases.

Y Van Nieuwenhove1, M Aerts, B Neyns, G Delvaux.   

Abstract

AIMS: For patients with unresectable liver metastases from colorectal cancer (CRC), hepatic artery infusion chemotherapy (HAIC) can produce higher response rates as compared to systemic chemotherapy. However, the added morbidity and early dysfunction after catheter placement have negatively influenced the outcomes of randomized studies.
METHODS: Between July 1998 and March 2006, 29 patients with unresectable liver metastases from CRC were included in three different HAIC protocols. A catheter was laparoscopically placed in the gastroduodenal artery, retrograde to the common hepatic artery and was attached to a subcutaneous access port. Perioperative parameters and catheter-associated adverse events during chemotherapy were studied.
RESULTS: Mean operating time was 106+/-29 min and median duration of hospitalization was 2 days (range: 1-13). No major perioperative complications occurred but there was 1 death (3.6%) 1 week after surgery due to hemorrhagic shock after necrosis and rupture of the hepatic artery. During a median follow-up of 10 months (range: 0-35) we observed 5 (17%) catheter-associated adverse events, but in only 2 patients (7%) this resulted in a loss of catheter function before the end of chemotherapy. Overall median duration of HAIC was 8 months (range: 1-28).
CONCLUSION: Laparoscopic placement of a hepatic artery catheter is associated with a low operative morbidity. The observed functionality of the hepatic artery ports in our series is encouraging for the use in future studies of HAIC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084580     DOI: 10.1016/j.ejso.2006.09.025

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab.

Authors:  K Van Bael; M Aerts; M de Ridder; J de Gréve; G Delvaux; B Neyns
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

2.  Cryotherapy for liver metastases.

Authors:  Malgorzata M Bala; Robert P Riemsma; Robert Wolff; Michal Pedziwiatr; Jerzy W Mitus; Dawid Storman; Mateusz J Swierz; Jos Kleijnen
Journal:  Cochrane Database Syst Rev       Date:  2019-07-10

3.  A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases.

Authors:  Kobe Van Bael; Yanina Jansen; Teofila Seremet; Benedikt Engels; Georges Delvaux; Bart Neyns
Journal:  Case Rep Oncol Med       Date:  2015-05-06

4.  Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases.

Authors:  Yanina J L Jansen; Gontran Verset; Kelly Schats; Pieter-Jan Van Dam; Teofila Seremet; Mark Kockx; Jean-Luc B Van Laethem; Bart Neyns
Journal:  ESMO Open       Date:  2019-03-05

5.  Laparoscopic intraarterial catheterization with selective ICG fluorescence imaging in colorectal surgery.

Authors:  Christian Heiliger; Jerzy Piecuch; Alexander Frank; Dorian Andrade; Viktor von Ehrlich-Treuenstätt; Dobromira Evtimova; Florian Kühn; Jens Werner; Konrad Karcz
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

6.  Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients.

Authors:  Stefano Bacchetti; Enricomaria Pasqual; Elena Crozzolo; Alessandra Pellarin; Pier Paolo Cagol
Journal:  Med Devices (Auckl)       Date:  2009-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.